Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Gore

Showing results (681-690 of 833) with videos related to

Pageof 84
Sort By:
Circulation|January 1, 1985
Effect of bepridil in patients with chronic stable angina: results of a multicenter trialJ A Hill, J T O'Brien, J S Alpert, et al.
The American Journal of Medicine|October 4, 2011
Long-term trends in short-term outcomes in acute myocardial infarctionHoa L Nguyen, Jane S Saczynski, Joel M Gore, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 16, 2002
Phase I trial of intraperitoneal injection of the E1B-55-kd-gene-deleted adenovirus ONYX-015 (dl1520) given on days 1 through 5 every 3 weeks in patients with recurrent/refractory epithelial ovarian cancerP A Vasey, L N Shulman, S Campos, et al.
American Heart Journal|November 25, 2010
Association between smoking, outcomes, and early clopidogrel use in patients with acute coronary syndrome: insights from the Global Registry of Acute Coronary EventsMatthew Sibbald, Andrew T Yan, Wei Huang, et al.
Journal of Multimorbidity and Comorbidity|March 29, 2024
Short and medium-term outcomes in individuals hospitalized with acute myocardial infarction and multiple chronic conditions: The Worcester heart attack studyChristopher Zammitti, Mayra Tisminetzky, Jordy Mehawej, et al.
Plos One|May 26, 2018
Efficacy and safety of direct oral anticoagulants approved for cardiovascular indications: Systematic review and meta-analysisRaghavendra Charan P Makam, David C Hoaglin, David D McManus, et al.
Annals of Internal Medicine|August 15, 1991
Hemorrhagic events during therapy with recombinant tissue-type plasminogen activator, heparin, and aspirin for acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI), Phase II TrialE G Bovill, M L Terrin, D C Stump, et al.
Journal of the American College of Cardiology|April 1, 1991
Selective versus routine predischarge coronary arteriography after therapy with recombinant tissue-type plasminogen activator, heparin and aspirin for acute myocardial infarction. TIMI II InvestigatorsW J Rogers, J D Babb, D S Baim, et al.
British Journal of Cancer|September 14, 2006
The multikinase inhibitor midostaurin (PKC412A) lacks activity in metastatic melanoma: a phase IIA clinical and biologic studyM J Millward, C House, D Bowtell, et al.
Cancers|May 13, 2023
Definitive Chemoradiation Associated with Improved Survival Outcomes in Patients with Synchronous Oligometastatic Esophageal CancerThomas Matoska, Anjishnu Banerjee, Aditya Shreenivas, et al.
Pageof 84

Showing results (681-690 of 833) with videos related to

Sort By:
Pageof 84
Circulation|January 1, 1985
Effect of bepridil in patients with chronic stable angina: results of a multicenter trialJ A Hill, J T O'Brien, J S Alpert, et al.
The American Journal of Medicine|October 4, 2011
Long-term trends in short-term outcomes in acute myocardial infarctionHoa L Nguyen, Jane S Saczynski, Joel M Gore, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 16, 2002
Phase I trial of intraperitoneal injection of the E1B-55-kd-gene-deleted adenovirus ONYX-015 (dl1520) given on days 1 through 5 every 3 weeks in patients with recurrent/refractory epithelial ovarian cancerP A Vasey, L N Shulman, S Campos, et al.
American Heart Journal|November 25, 2010
Association between smoking, outcomes, and early clopidogrel use in patients with acute coronary syndrome: insights from the Global Registry of Acute Coronary EventsMatthew Sibbald, Andrew T Yan, Wei Huang, et al.
Journal of Multimorbidity and Comorbidity|March 29, 2024
Short and medium-term outcomes in individuals hospitalized with acute myocardial infarction and multiple chronic conditions: The Worcester heart attack studyChristopher Zammitti, Mayra Tisminetzky, Jordy Mehawej, et al.
Plos One|May 26, 2018
Efficacy and safety of direct oral anticoagulants approved for cardiovascular indications: Systematic review and meta-analysisRaghavendra Charan P Makam, David C Hoaglin, David D McManus, et al.
Annals of Internal Medicine|August 15, 1991
Hemorrhagic events during therapy with recombinant tissue-type plasminogen activator, heparin, and aspirin for acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI), Phase II TrialE G Bovill, M L Terrin, D C Stump, et al.
Journal of the American College of Cardiology|April 1, 1991
Selective versus routine predischarge coronary arteriography after therapy with recombinant tissue-type plasminogen activator, heparin and aspirin for acute myocardial infarction. TIMI II InvestigatorsW J Rogers, J D Babb, D S Baim, et al.
British Journal of Cancer|September 14, 2006
The multikinase inhibitor midostaurin (PKC412A) lacks activity in metastatic melanoma: a phase IIA clinical and biologic studyM J Millward, C House, D Bowtell, et al.
Cancers|May 13, 2023
Definitive Chemoradiation Associated with Improved Survival Outcomes in Patients with Synchronous Oligometastatic Esophageal CancerThomas Matoska, Anjishnu Banerjee, Aditya Shreenivas, et al.
Pageof 84